Friday - May 12, 2017

The events include two cycle rides, a triathlon and a host of smaller individual fundraising activities

Bayer fundraisers launch three major events this summer

More than 300 energetic and charity-minded Bayer colleagues have launched three of their most ambitious fundraising activities to date as they strive to raise thousands for their favourite charities this summer.

Flashback to the start of the 2016 cycle ride
Flashback to the start of the 2016 cycle ride

Last year two groups from the company’s General Medicine and Country Platform (business services) team raised more than £33,000 after completing a cycle ride from London to Leverkusen in Germany.  This year colleagues from each office have set themselves equally stiff targets as they attempt to match their targets of last year.



A 40-strong group from Reading and Cambridge offices will be cycling from Reading to Paris, starting on June 8, to raise money for hospices Naomi House and Jacksplace, with a target of £20,000, and on July 7 the entire General Medicine team will be taking part in a triathlon, either as participants or as support crew, at a venue in Leiceistershire.  They hope to raise £25,000 for Together For Short Lives, the leading UK charity which supports seriously ill children and their families.



Meanwhile colleagues from the company’s Dublin office will also be saddling up for a four-day cycle ride from Dublin to Windsor, from June 4, calling in at Bayer’s Reading office in Green Park.  They have set themselves a target of raising 8,000 Euros. Their money will go towards their nominated charity, the children’s hospice LauraLynn.



All the offices have already kicked off fundraising with smaller activities such as raffles, cake sales and pedal-thons.



Head of Corporate Communications, Simon Greenstreet, said: “These teams were truly inspired by what they and other colleagues achieved last year, and wanted to continue the momentum into 2017. They have devised very challenging activities which involve a lot of work in terms of training and preparation.  It will help to bring the best out of themselves when the big occasion arrives, and hopefully to raise many more thousands of pounds to charities which help make children and their families’ lives a lot better.”

Contact:

Bayer media team: 01635 563000

Sara Bartlett: 07787 571020


Notes to Editors

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

 

Bayer’s offices in the UK and Ireland are located in Reading (head office), Cambridge and Dublin. For more information, go to www.bayer.co.uk


Follow us on Twitter at: https://twitter.com/UKBayer
Follow us on Facebook at: https://www.facebook.com/UKBayer
Follow us on YouTube at: www.youtube.com/BayerUKIre

 

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.